Mechanisms and cell signaling in alcoholic liver disease
- 24 September 2010
- journal article
- review article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 391 (11), 1249-1264
- https://doi.org/10.1515/bc.2010.137
Abstract
Alcoholic liver disease (ALD) remains a major cause of morbidity and mortality worldwide. For example, the Veterans Administration Cooperative Studies reported that patients with cirrhosis and superimposed alcoholic hepatitis had a 4-year mortality of >60%. The poor prognosis of ALD implies that preventing disease progression would be more effective than treating end-stage liver disease. An obvious avenue of prevention would be to remove the damaging agent; however, the infamously high rate of recidivism in alcoholics makes maintaining abstinence a difficult treatment goal to prevent ALD. Indeed, although the progression of ALD is well-characterized, there is no universally accepted therapy available to halt or reverse this process in humans. With better understanding of the mechanism(s) and risk factors that mediate the initiation and progression of ALD, rational targeted therapy can be developed to treat or prevent ALD. The purpose of this review is to summarize the established and proposed mechanisms by which chronic alcohol abuse damages the liver and to highlight key signaling events known or hypothesized to mediate these effects.Keywords
This publication has 134 references indexed in Scilit:
- Redox Regulation of Tumor Necrosis Factor SignalingAntioxidants and Redox Signaling, 2009
- Signalling pathways in alcohol-induced liver inflammationJournal of Hepatology, 2009
- α v β 3 –Targeted nanotherapy suppresses inflammatory arthritis in miceThe FASEB Journal, 2009
- PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditureCurrent Opinion in Lipidology, 2009
- Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in miceHepatology, 2009
- A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic HepatitisGastroenterology, 2008
- The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88Hepatology, 2008
- New role of plasminogen activator inhibitor‐1 in alcohol‐induced liver injuryJournal of Gastroenterology and Hepatology, 2008
- Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: Possible involvement of mitochondrial S-adenosylmethionine transportBiochemical Pharmacology, 2007
- Metformin Prevents Alcohol-Induced Liver Injury in the Mouse: Critical Role of Plasminogen Activator Inhibitor-1Gastroenterology, 2006